Bayer launches Medrad Mark 7 Arterion Injection System

413

BayerMark7Arterion_web_05_Main

Bayer HealthCare’s Radiology and Interventional unit has launched the new Mark 7 Arterion Injection System, the latest in the Medrad Mark series of angiographic injectors used to diagnose cardiovascular disease.

“The Arterion injection system was designed with efficiency in mind,” said Diane Watson, head of Interventional Fluid Delivery at Bayer HealthCare’s Radiology and Interventional unit. “It is light and maneuverable with features that are meant to simplify the delivery of contrast media used in angiograms to determine the extent of arterial blockage.”

The first Medrad Mark injector was introduced for use in angiograms more than 40 years ago.

“The Mark 7 Arterion system’s user interface facilitates the setting up and performing of contrast injections,” said Robyn Reising, of Decatur Memorial Hospital where the very first Arterion system was installed in the USA. “The front-load system shall streamline the pre and post-procedure activities and the clear syringe allows us to monitor the purging of air.”